Safety and Efficacy of Standard of Care Ciltacabtagene Autoleucel for Relapsed/Refractory Multiple Myeloma

Sidana, S., Patel, K. K., Peres, L. C., Bansal, R., Kocoglu, M. H., Shune, L., Atrash, S., Smith, K., Midha, S., Ferreri, C. J., Dhakal, B., Dima, D., Costello, P., Wagner, C., Reshef, R., Hosoya, H., Mikkilineni, L., Atanackovic, D., Chhabra, S., … Hansen, D. K. (2024). Safety and Efficacy of Standard of Care Ciltacabtagene Autoleucel for Relapsed/Refractory Multiple Myeloma. Blood Journal. https://doi.org/10.1182/blood.2024025945
Authors:
Surbhi Sidana
Krina K Patel
Lauren C Peres
Radhika Bansal
Mehmet Hakan Kocoglu
Leyla Shune
Shebli Atrash
Kinaya Smith
Shonali Midha
Christopher J Ferreri
Binod Dhakal
Danai Dima
Patrick Costello
Charlotte Wagner
Ran Reshef
Hitomi Hosoya
Lekha Mikkilineni
Djordje Atanackovic
Saurabh Chhabra
Ricardo D Parrondo
Omar Nadeem
Hashim Mann
Nilesh Kalariya
Vanna Hovanky
Gabriel DeAvila
Ciara L Freeman
Frederick L Locke
Melissa Alsina
Sandy Wong
Megan M Herr
Myo Htut
Joseph P McGuirk
Douglas W Sborov
Jack Khouri
Thomas Martin
Murali Janakiram
Yi Lin
Doris K Hansen
Affiliated Authors:
Ran Reshef
Columbia Affiliation:
elink
Publication Type:
Article
Unique ID:
10.1182/blood.2024025945
PMID:
39365257
DOI:
10.1182/blood.2024025945
Journal:
Blood
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record
View Scopus Record
View Web of Science Record

Record Created: